• 1. Guangdong General Hospital (Guangdong Academy of Medical Sciences), Department of Pediatrics, Guangzhou 510080, China;
  • 2. Pediatric Intensive Care Unit, Guangzhou 510080, China;
ZHAI Qiongxiang, Email: zhaiqiongxiang@sina.com
Export PDF Favorites Scan Get Citation

Objective  To study the efficacy and adverse events of adjunctive perampanel in children with refractory epilepsy. Methods  A prospective study was carried out in 45 children with refractory epilepsy, who were treated in our hospital from January 2020 to February 2021 using perampanel as an add-on treatment, with a criteria for enrollment and the starting dose of perampanel. Follow-up would be taken at once a month. Afte 3 months would check blood routine, liver function, kidney function and humoral immunity. The EEG was reviewed after 6 months. The initial dose of perampanel was 0.04 mg/(kg·d) (the maximum didn't exceed 2 mg/d), increasing by 0.04 mg/(kg·d) every two weeks, and the maximum maintenance dose didn't exceed 6 mg/d. The efficacy and adverse reactions of perampanel were evaluated by comparing the seizure frequency and EEG results before and after a 6-month add-on therapy.Results Among the 45 children,complete seizure control was achieved in 7 cases after the therapy, and the seizure attacks were reduced in 26 cases, showing a total response rate of 73.3%. After the treatment, the epileptiform discharge of 28 children was reduced, and the effective rate was 62.22%. During the observation period, all the blood routine, liver function, kidney function,and humoral immunity of the children were normal.10 cases of adverse reactions occurred after the additional treatment of perampanel, and the adverse reaction rate was 22.22%. Conclusions  Perampanel has good efficacy and safety in the add-on treatment of refractory epilepsy.

Citation: ZHANG Jingwen, ZHANG Yuxin, LI Xufeng, LIANG Mingjuan, WANG Chun, GUO Yuxiong, CHEN Zhihong, ZHAI Qiongxiang. Clinical study of the adjunctive treatment of perampanel in children with refractory epilepsy. Journal of Epilepsy, 2022, 8(3): 232-235. doi: 10.7507/2096-0247.202112007 Copy

  • Previous Article

    The aetiology and prognosis of convulsive status epilepticus: a study of 331 cases in Tibet Lhasa area
  • Next Article

    癫痫所致生殖内分泌功能障碍的研究进展